Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ruisheng Ke
Observed names:
Ke Ruisheng,
Rui-Sheng Ke,
Rui-sheng Ke,
RuiSheng Ke
Institution:
First Affiliated Hospital of Xiamen University
Observed institutions:
Fujian Medical University,
Xiamen University,
First Affiliated Hospital of Xiamen University,
Fuzhou General Hospital of Nanjing Military Command
ORCID:
0000-0001-9269-4692
Observed ORCID:
0000-0001-9269-4692
OpenAlex ID:
A5075856503
DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma
2017
·
Yi Cao
, Ruisheng Ke
, et al.
·
Oncology Letters
·
44
PDF
Prognostic value and oncogene function of heterogeneous nuclear ribonucleoprotein A1 overexpression in HBV-related hepatocellular carcinoma
2019
·
Rui-sheng Ke
, Kun Zhang
, et al.
·
International Journal of Biological Macromolecules
·
30
Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis
2020
·
Chongfa Chen
, Ruisheng Ke
, et al.
·
Medicine
·
29
A Novel Ferroptosis-Related Gene Signature For Clinically Predicting Recurrence After Hepatectomy of Hepatocellular Carcinoma Patients.
2021
·
Huaxiang Wang
, Fengfeng Xu
, et al.
·
Research Square
·
25
PDF
Functional mechanism and clinical implications of MicroRNA‐423 in human cancers
2020
·
RuiSheng Ke
, LiZhi Lv
, et al.
·
Cancer Medicine
·
25
PDF
miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway
2021
·
Zhe-Long Jiang
, Fu-Xing Zhang
, et al.
·
Biochemical Genetics
·
24
Prognostic value of heterogeneous ribonucleoprotein A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China
2018
·
Ruisheng Ke
, Lizhi Lv
, et al.
·
Oncology Letters
·
13
PDF
Impact of lncRNA SOX9-AS1 overexpression on the prognosis and progression of intrahepatic cholangiocarcinoma
2022
·
Lupeng Wu
, Jingrui Yang
, et al.
·
Clinics and Research in Hepatology and Gastroenterology
·
10
miR-3178 as a prognostic indicator and tumor suppressor of gastric cancer
2021
·
Jin-cheng Wu
, Zhao-hui Liu
, et al.
·
Irish Journal of Medical Science (1971 -)
·
8
[Erratum] Prognostic value of heterogeneous ribonucleoprotein�A1 expression and inflammatory indicators for patients with surgically resected hepatocellular carcinoma: Perspectives from a high occurrence area of hepatocellular carcinoma in China
2018
·
Ruisheng Ke
, Lizhi Lv
, et al.
·
Oncology Letters
·
7
PDF
miR-369-3p Serves as Prognostic Factor and Regulates Cancer Progression of Hepatocellular Carcinoma
2021
·
Can Chen
, Yi Zong
, et al.
·
Personalized Medicine
·
5
miR-517b-3p promotes the progression of portal vein tumor thrombus via activating Wnt/β-catenin signaling pathway in hepatocellular carcinoma
2022
·
Rui-Sheng Ke
, Kun-Zhai Huang
, et al.
·
Molecular Biology Reports
·
4
PDF
Comparison of the Safety and Thoroughness of Preoperative Versus Intraoperative Injection of Nanocarbon Tracers in Thyroid Cancer Surgery
2022
·
Hongliang Zhan
, Heqing Huang
, et al.
·
Indian Journal of Surgery
·
4
Diagnosis and treatment of microvascular invasion in hepatocellular carcinoma
2019
·
Rui-Sheng Ke
, Qiu-cheng Cai
, et al.
·
European surgery. Supplement/European surgery
·
3
COLEC10: A potential tumor suppressor and prognostic biomarker in hepatocellular carcinoma through modulation of EMT and PI3K-AKT pathways
2025
·
Rui-Sheng Ke
, Yun Dai
, et al.
·
Open Life Sciences
·
2
Ki-67 and DNA topoisomerase IIα predict survival in patients with primary hepatocellular carcinoma after liver transplantation
2016
·
Jie Yang
, Yi Cao
, et al.
·
Zhonghua gan-dan waike zazhi
·
1
Comparative Performance of the 2015 and 2025 American Thyroid Association Initial Recurrence Risk Stratification Systems in Differentiated Thyroid Cancer
2026
·
Weixun Ke
, Xuanling Zheng
, et al.
·
Thyroid
DACT1 as a Potential Therapeutic Target in Gastric Cancer: Insights from Integrative Bioinformatics and Experimental Analysis
2025
·
Rui-Sheng Ke
, Bing Bai
, et al.
·
Journal of Environmental Pathology Toxicology and Oncology
Prediction of lymph node metastasis in stage I–III colon cancer patients younger than 40 years
2025
·
Wei-Hao Zhang
, Meng-Di Huang
, et al.
·
Clinical & Translational Oncology
LINC02875 Upregulation Contributed to Poor Prognosis for the Hepatocellular Carcinoma and Progression for the Cancerous Cells
2022
·
Yujian Liu
, Jingrui Yang
, et al.
·
Hormone and Metabolic Research
Analysis of early infection and bacterial drug resistance in liver transplant patients from organ donation after death
2019
·
Huaxiang Wang
, Fengfeng Xu
, et al.
·
Chin J Hepat Surg(Electronic Edition)
Advances in the application of model for end-stage liver disease and MELD-Na scores in liver transplantation
2019
·
Yongtai Chen
, Ruisheng Ke
, et al.
·
Chin Arch Gen Surg(Electronic Edition)
The expression of GHET1 in hepatocellular carcinoma and its effect on prognosis of the patients
2018
·
Yangping Zhang
, Ruisheng Ke
, et al.
·
Zhonghua gan-dan waike zazhi
Biliary complications and recovery of liver function after liver transplantation from citizen’s deceased donors versus standard criteria donors
2018
·
Huaxiang Wang
, Ruisheng Ke
, et al.
·
Zhonghua gan-dan waike zazhi
Relationship of HnRNPA1 expression in patients with recurrent and metastatic hepatocellular carcinoma after liver transplantation
2017
·
Ruisheng Ke
, Jiayan Li
, et al.
·
Zhonghua gan-dan waike zazhi
Show more works
View as search
Works count:
27
Citation count:
234
H-index:
8
I10-index:
8
Year
Topic
Type